BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1381790)

  • 1. Effects of converting enzyme inhibitors on coronary flow and myocardial ischemia.
    van Gilst WH; Tio RA; van Wijngaarden J; de Graeff PA; Wesseling H
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S134-9. PubMed ID: 1381790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of angiotensin-converting enzyme inhibition on coronary vasomotion in hypertensive patients.
    Nitenberg A; Antony I
    Eur Heart J; 1998 Sep; 19 Suppl J():J45-51. PubMed ID: 9796840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Possibilities of ACE inhibitor therapy in acute myocardial ischemia].
    Ertl G; Bauer B; Gaudron P; Neubauer S; Schorb W; Kochsiek K
    Klin Wochenschr; 1991; 69 Suppl 24():10-7; discussion 18-9. PubMed ID: 1865631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sympathetic nervous system and ischaemic heart disease.
    Remme WJ
    Eur Heart J; 1998 Jun; 19 Suppl F():F62-71. PubMed ID: 9651738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The significance of converting enzyme inhibitor angiotensin I to angiotensin II in treatment of patients with coronary disease].
    Halawa B
    Pol Merkur Lekarski; 1998 Jan; 4(19):32-4. PubMed ID: 9553407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential influences of angiotensin converting-enzyme inhibitors on the coronary circulation.
    van Gilst WH; Scholtens E; de Graeff PA; de Langen CD; Wesseling H
    Circulation; 1988 Jun; 77(6 Pt 2):I24-9. PubMed ID: 3286044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of bradykinin on coronary flow and its potentiation by SH-containing ACE-inhibitors.
    de Graeff PA; van Gilst WH
    Agents Actions Suppl; 1992; 38 ( Pt 3)():110-8. PubMed ID: 1462853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local regulation of vascular tone by bradykinin and angiotensin converting enzyme inhibitors.
    Auch-Schwelk W; Kuchenbuch C; Claus M; Walther B; Bossaller C; Friedel N; Graf K; Gräfe M; Fleck E
    Eur Heart J; 1993 Nov; 14 Suppl I():154-60. PubMed ID: 8293767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of bradykinin and the ischemic isolated rat heart.
    Tio RA; van Gilst WH; Rett K; Wolters K; Dietze GJ; Wesseling H
    Horm Metab Res Suppl; 1990; 22():85-9. PubMed ID: 2167866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The coronary circulation, renin-angiotensin system and ACE inhibition].
    Campa PP
    Cardiologia; 1995 Sep; 40(9):635-41. PubMed ID: 8542615
    [No Abstract]   [Full Text] [Related]  

  • 11. Converting-enzyme inhibition and coronary blood flow.
    Magrini F; Shimizu M; Roberts N; Fouad FM; Tarazi RC; Zanchetti A
    Circulation; 1987 Jan; 75(1 Pt 2):I168-74. PubMed ID: 3024863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
    Bauer WR; Neubauer S; Obitz G; Ertl G
    J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary vascular reactivity and calcium antagonist therapy in patients with angina.
    Perondi R; Saino A; Zanchetti A; Mancia G
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S30-6. PubMed ID: 7603075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local inhibition of bradykinin degradation in ischemic hearts.
    Linz W; Martorana PA; Schölkens BA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Angiotensin-converting enzyme inhibitors and ischemic heart disease].
    Ertl G; Kochsiek K
    Dtsch Med Wochenschr; 1989 Apr; 114(14):556-60. PubMed ID: 2649347
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors and the kallikrein-kinin system.
    Shimamoto K; Matsuki T; Iimura O
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S83-90. PubMed ID: 1697368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary endothelial vasodilator dysfunction: clinical relevance and therapeutic implications.
    Zeiher AM; Schächinger V
    Z Kardiol; 1994; 83 Suppl 4():7-14. PubMed ID: 7856284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE inhibition attenuates sympathetic coronary vasoconstriction in patients with coronary artery disease.
    Perondi R; Saino A; Tio RA; Pomidossi G; Gregorini L; Alessio P; Morganti A; Zanchetti A; Mancia G
    Circulation; 1992 Jun; 85(6):2004-13. PubMed ID: 1591820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.